Delivery Order SPE2DB22D1103-SPE2DB25FH0A5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,405.78 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on June 18, 2025, with a completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $9,379.27 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order is issued without set-aside status, indicating competitive award based on open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,717.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,113.92 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $13,775.88 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pens on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a single-line pharmaceutical procurement supporting federal medical supply requirements. The order is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with a ceiling value of $1,904.63 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $5,564.41. This delivery order, issued under a firm fixed-price contract with no set-aside designation, is due for completion by July 14, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a primary pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $11,592.97 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the place of performance for this transaction. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical procurement supporting military and federal healthcare needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH0A5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,573.79 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement within AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a primary pharmaceutical distributor for federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime vendor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications and medical commodities to support Defense Health Agency and other military healthcare systems. The Mounjaro procurement supports federal healthcare requirements and demonstrates the company's role as a critical vendor in the Defense Logistics Agency's pharmaceutical supply chain for the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/13/25 |